BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 12942570)

  • 1. Evaluation of dietetic intervention in children with medulloblastoma or supratentorial primitive neuroectodermal tumors.
    Bakish J; Hargrave D; Tariq N; Laperriere N; Rutka JT; Bouffet E
    Cancer; 2003 Sep; 98(5):1014-20. PubMed ID: 12942570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
    Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
    Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A
    J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
    Biswas S; Burke A; Cherian S; Williams D; Nicholson J; Horan G; Jefferies S; Williams M; Earl HM; Burnet NG; Hatcher H
    Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor.
    Paulino AC; Cha DT; Barker JL; Lo S; Manera RB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1171-6. PubMed ID: 15001261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.
    Robertson PL; Muraszko KM; Holmes EJ; Sposto R; Packer RJ; Gajjar A; Dias MS; Allen JC;
    J Neurosurg; 2006 Dec; 105(6 Suppl):444-51. PubMed ID: 17184075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors.
    Kao GD; Goldwein JW; Schultz DJ; Radcliffe J; Sutton L; Lange B
    Cancer; 1994 Aug; 74(3):965-71. PubMed ID: 8039126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of therapy on nutritional status of the pediatric cancer patient.
    Donaldson SS
    Cancer Res; 1982; 42(2 Suppl):729s-736s. PubMed ID: 6799191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
    J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of radiation in children with medulloblastoma/PNET.
    Santos MA; Viégas CM; Servidoni RA; Barros MH; Pinel MI; Araújo CM
    Pediatr Blood Cancer; 2007 Apr; 48(4):416-22. PubMed ID: 17034032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive nutrition education with or without supplementary feeding improves the nutritional status of moderately-malnourished children in Bangladesh.
    Roy SK; Fuchs GJ; Mahmud Z; Ara G; Islam S; Shafique S; Akter SS; Chakraborty B
    J Health Popul Nutr; 2005 Dec; 23(4):320-30. PubMed ID: 16599102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
    Grotzer MA; Janss AJ; Phillips PC; Trojanowski JQ
    Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy intakes of children with Crohn's disease treated with enteral nutrition as primary therapy.
    Gavin J; Anderson CE; Bremner AR; Beattie RM
    J Hum Nutr Diet; 2005 Oct; 18(5):337-42. PubMed ID: 16150129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
    Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa.
    Packer RJ
    Ann Neurol; 1990 Dec; 28(6):823-8. PubMed ID: 2178331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
    Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
    Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
    Allen JC; Donahue B; DaRosso R; Nirenberg A
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.